Impact of daclizumab, low-dose cyclosporine, mycophenolate mofetil and steroids on renal function after kidney transplantation

Fangmann, Josef; Arns, Wolfgang; Marti, Hans-Peter; Hauss, Johann; Ketteler, Markus; Beckurts, Tobias; Boesmueller, Claudia; Pohanka, Erich; Martin, Pierre-Yves; Gerhardt, Moritz; Farese, Stefan; Neumayer, Hans-H; Floege, Juergen; Gurr, Caroline; Budde, Klemens; DACH Study Group, (2010). Impact of daclizumab, low-dose cyclosporine, mycophenolate mofetil and steroids on renal function after kidney transplantation. Nephrology, dialysis, transplantation, 25(1), pp. 283-92. Oxford: Oxford University Press 10.1093/ndt/gfp468

[img]
Preview
Text
gfp468.pdf - Published Version
Available under License Publisher holds Copyright.

Download (372kB) | Preview

Early and long-term use of cyclosporine A (CsA) leads to increased risks of renal toxicity. We hypothesized that administration of daclizumab in combination with mycophenolate mofetil (MMF) allows a relevant reduction in the dose of CsA.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Dermatology, Urology, Rheumatology, Nephrology, Osteoporosis (DURN) > Clinic of Nephrology and Hypertension

UniBE Contributor:

Marti, Hans-Peter

ISSN:

0931-0509

Publisher:

Oxford University Press

Language:

English

Submitter:

Factscience Import

Date Deposited:

04 Oct 2013 14:11

Last Modified:

27 Apr 2018 09:32

Publisher DOI:

10.1093/ndt/gfp468

PubMed ID:

19773417

Web of Science ID:

000273113100047

BORIS DOI:

10.7892/boris.1796

URI:

https://boris.unibe.ch/id/eprint/1796 (FactScience: 203822)

Actions (login required)

Edit item Edit item
Provide Feedback